LUMO

Lumos Pharma (LUMO)

About Lumos Pharma (LUMO)

Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for rare diseases. Its product includes LUM-201, an oral growth hormone stimulating small molecule for the treatment of pediatric growth hormone deficiency (PGHD). The company was founded on June 4, 1999 and is headquartered in Austin, TX.

Details

Daily high

$3.85

Daily low

$3.66

Price at open

$3.88

52 Week High

$4.55

52 Week Low

$1.37

Market cap

30.8M

Dividend yield

0.00%

Volume

6,518

Avg. volume

28,839

P/E ratio

-.86

Lumos Pharma News